• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 年至 2009 年植入式心脏复律除颤器的使用和长期疗效。

Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009.

机构信息

School of Population Health, University of Western Australia, Perth, Western Australia.

出版信息

Am Heart J. 2013 May;165(5):816-22. doi: 10.1016/j.ahj.2013.02.007. Epub 2013 Mar 19.

DOI:10.1016/j.ahj.2013.02.007
PMID:23622920
Abstract

BACKGROUND

Automated implantable cardioverter-defibrillators (ICDs) have become standard therapy for patients at high risk for sudden cardiac death. Linked data allow examination of trends in use and long-term survival after ICD implantation in an adult population.

METHODS

Linked state-wide person-based data on hospital admissions and deaths from 1980 to 2009 were used to identify incident cases of ICD implantation. Population rates were calculated using census data. Kaplan-Meier techniques were used to describe cumulative survival. Cox regression models were used to determine the factors associated with the outcomes.

RESULTS

Between 1988 and 2009, 1593 devices were implanted in patients in Western Australia, rising from 2 in 1988 to 245 in 2009; standardized population rates rose from 0.8 in 100000 in 1995 to 14.9 in 100000 in 2009. Mean age rose from 52.6 (SD 11.6) to 64.1 (11.4) years. Ventricular tachycardia (23%), cardiomyopathy (18%), and heart failure (16%) were the most frequent principal diagnoses. Ischemic heart disease was present in 49% of patients. Five-year cumulative survival was 0.74 (SE 0.01), and at 10 years, 0.53 (SE 0.03); median survival was 11.3 years. Readmission within a year, older age, heart failure, device complications, and chronic ischemic heart disease were associated with poorer survival.

CONCLUSIONS

Implantable cardioverter-defibrillator use in adults at risk for sudden cardiac death has grown rapidly. Readmission within 12 months of discharge is associated with worse medium and long-term mortality. Survival for most patients younger than 65 years exceeds 10 years and 5 years for those aged ≥75 years.

摘要

背景

自动植入式心脏除颤器(ICD)已成为高危心源性猝死患者的标准治疗方法。关联数据允许检查在成人人群中 ICD 植入后的使用趋势和长期生存率。

方法

使用 1980 年至 2009 年全州范围内的住院和死亡人员关联数据,确定 ICD 植入的病例。使用人口普查数据计算人口率。采用 Kaplan-Meier 技术描述累积生存率。采用 Cox 回归模型确定与结局相关的因素。

结果

1988 年至 2009 年间,西澳大利亚州共植入了 1593 台设备,从 1988 年的 2 台增加到 2009 年的 245 台;标准化人口率从 1995 年的每 10 万人 0.8 上升到 2009 年的每 10 万人 14.9。平均年龄从 52.6(11.6)岁增加到 64.1(11.4)岁。室性心动过速(23%)、心肌病(18%)和心力衰竭(16%)是最常见的主要诊断。5 年累积生存率为 0.74(SE 0.01),10 年生存率为 0.53(SE 0.03);中位生存期为 11.3 年。出院后 1 年内再入院、年龄较大、心力衰竭、器械并发症和慢性缺血性心脏病与生存率较差相关。

结论

高危心源性猝死的成人患者中,植入式心脏除颤器的使用迅速增加。出院后 12 个月内再入院与中、长期死亡率较高相关。大多数年龄小于 65 岁的患者的生存率超过 10 年,年龄大于 75 岁的患者的生存率超过 5 年。

相似文献

1
Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009.1990 年至 2009 年植入式心脏复律除颤器的使用和长期疗效。
Am Heart J. 2013 May;165(5):816-22. doi: 10.1016/j.ahj.2013.02.007. Epub 2013 Mar 19.
2
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.植入式心律转复除颤器预防肥厚型心肌病儿童和青少年心源性猝死。
J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.
3
Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.肥厚型心肌病患者的植入式心脏复律除颤器:长期随访中的疗效和治疗并发症。
J Cardiovasc Electrophysiol. 2010 Aug 1;21(8):883-9. doi: 10.1111/j.1540-8167.2009.01716.x. Epub 2010 Feb 1.
4
Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.导致冠心病或非缺血性扩张型心肌病患者 ICD 干预的致室性心律失常的相关因素。
Kardiol Pol. 2012;70(12):1264-75.
5
Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.植入式心脏复律除颤器用于恰加斯心脏病二级预防的长期随访。
Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.
6
[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].[植入式心脏复律除颤器的14年经验:预后和出院行为的判定]
Z Kardiol. 2000;89 Suppl 3:194-205.
7
Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.未接受过适当植入式心脏复律除颤器治疗的死亡:一项竞争风险研究。
Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.
8
Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.植入式心脏复律除颤器在降低中国人群心源性猝死中的预防效果:一项 ICD 治疗与非 ICD 治疗的多中心试验。
J Cardiovasc Electrophysiol. 2012 Nov;23 Suppl 1:S5-9. doi: 10.1111/j.1540-8167.2012.02435.x.
9
Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.植入心脏复律除颤器的患者在用于心脏性猝死一级预防与二级预防时的生存率及适当的设备干预情况。
Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S16-20. doi: 10.1111/j.1540-8159.2008.02222.x.
10
Application of a mortality risk score in a general population of patients with an implantable cardioverter defibrillator (ICD).应用于植入式心脏复律除颤器(ICD)患者的一般人群的死亡率风险评分。
Heart. 2014 Mar;100(6):487-91. doi: 10.1136/heartjnl-2013-305002. Epub 2014 Jan 10.

引用本文的文献

1
Presence of Permanent Pacemakers: Implications for Elderly Patients Presenting with Traumatic Injuries.永久性起搏器的存在:对创伤性损伤老年患者的影响。
Trauma Surg Acute Care Open. 2023 Jun 13;8(1):e001053. doi: 10.1136/tsaco-2022-001053. eCollection 2023.
2
Suicide Attempt Following Pacemaker Implantation in an Eighty-Three-Year-Old Male: A Case Report.一名83岁男性植入起搏器后自杀未遂:病例报告
J Med Cases. 2019 Dec;10(12):345-347. doi: 10.14740/jmc3383. Epub 2019 Dec 31.
3
Primary Prevention Implantable Cardiac Defibrillators: A Townsville District Perspective.
原发性预防植入式心脏除颤器:汤斯维尔地区视角
Front Cardiovasc Med. 2020 Oct 27;7:577248. doi: 10.3389/fcvm.2020.577248. eCollection 2020.
4
Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population.老年人群中心脏起搏器植入的发病率和患病率趋势。
Open Heart. 2014 Dec 10;1(1):e000177. doi: 10.1136/openhrt-2014-000177. eCollection 2014.